Tvardi Therapeutics, Inc.
USD2.95
-0.22 (-6.94%)
CEO
Imran Alibhai
IPO Date
2025-04-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.15
Prev. Close
$3.17
Day Low
$2.92
Day High
$3.22
52W Low
$2.75
52W High
$43.65
Market Cap
$0.03B
Volume
0.06M
| 45,000 |
| $3.90 |
| 2 Feb 2026 | Kauh John Saewook M.D. | Chief Medical Officer | A-Award | Acquired | 45,000 | $3.90 |
| 2 Feb 2026 | Alibhai Imran Nizamudin | director, officer: Chief Executive Officer | A-Award | Acquired | 115,000 | $3.90 |
| 18 Dec 2025 | O'Brien Stephen Paul | Principal Accounting Officer | A-Award | Acquired | 4,000 | $4.20 |
| 18 Dec 2025 | Kauh John Saewook M.D. | Chief Medical Officer | A-Award | Acquired | 17,500 | $4.20 |
| 18 Dec 2025 | Conn Avi Daniel | Chief Financial Officer | A-Award | Acquired | 17,500 | $4.20 |
| 18 Dec 2025 | Alibhai Imran Nizamudin | director, officer: Chief Executive Officer | A-Award | Acquired | 47,500 | $4.20 |
| 5 Aug 2025 | Tweardy Samuel David | 10 percent owner | J-Other | Disposed | 315,658 | $0.00 |
| 21 Apr 2025 | Shah Sujal | director | A-Award | Acquired | 12,000 | $17.04 |